These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 26997358)

  • 1. Low oxygen tension favored expansion and hematopoietic reconstitution of CD34(+) CD38(-) cells expanded from human cord blood-derived CD34(+) Cells.
    Wang Z; Du Z; Cai H; Ye Z; Fan J; Tan WS
    Biotechnol J; 2016 Jul; 11(7):945-53. PubMed ID: 26997358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential ability of MSCs isolated from placenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34(+) cells.
    Kadekar D; Kale V; Limaye L
    Stem Cell Res Ther; 2015 Oct; 6():201. PubMed ID: 26481144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic repopulating ability of CD34⁺ progenitor cells ex vivo expanded with different cytokine combinations.
    Du Z; Jin H; Cai H; Yang S; Tan WS
    Artif Cells Nanomed Biotechnol; 2015; 43(6):398-402. PubMed ID: 24665846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo expansion of cord blood haematopoietic stem/progenitor cells under physiological oxygen tensions: clear-cut effects on cell proliferation, differentiation and metabolism.
    Andrade PZ; de Soure AM; Dos Santos F; Paiva A; Cabral JM; da Silva CL
    J Tissue Eng Regen Med; 2015 Oct; 9(10):1172-81. PubMed ID: 23596131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic cell-cell interactions between cord blood haematopoietic progenitors and the cellular niche are essential for the expansion of CD34+, CD34+CD38- and early lymphoid CD7+ cells.
    da Silva CL; Gonçalves R; dos Santos F; Andrade PZ; Almeida-Porada G; Cabral JM
    J Tissue Eng Regen Med; 2010 Feb; 4(2):149-58. PubMed ID: 19937912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel alginate three-dimensional static and rotating culture systems for effective ex vivo amplification of human cord blood hematopoietic stem cells and in vivo functional analysis of amplified cells in NOD/SCID mice.
    Yuan Y; Sin WY; Xue B; Ke Y; Tse KT; Chen Z; Xie Y; Xie Y
    Transfusion; 2013 Sep; 53(9):2001-11. PubMed ID: 23384125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell factor is essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded cord blood CD34(+) cells.
    Du Z; Wang Z; Zhang W; Cai H; Tan WS
    Cell Prolif; 2015 Jun; 48(3):293-300. PubMed ID: 25899394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic reconstitution of CD34+ cells grown in static and stirred culture systems in NOD/SCID mice.
    Yang S; Cai H; Jin H; Tan WS
    Biotechnol Lett; 2008 Jan; 30(1):61-5. PubMed ID: 17846707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S; Law P; Young D; Ho AD
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
    Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
    Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein.
    Suzuki T; Yokoyama Y; Kumano K; Takanashi M; Kozuma S; Takato T; Nakahata T; Nishikawa M; Sakano S; Kurokawa M; Ogawa S; Chiba S
    Stem Cells; 2006 Nov; 24(11):2456-65. PubMed ID: 16857897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Karyotyping, immunophenotyping, and apoptosis analyses on human hematopoietic precursor cells derived from umbilical cord blood following long-term ex vivo expansion.
    Tian H; Huang S; Gong F; Tian L; Chen Z
    Cancer Genet Cytogenet; 2005 Feb; 157(1):33-6. PubMed ID: 15676144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells.
    Yao CL; Feng YH; Lin XZ; Chu IM; Hsieh TB; Hwang SM
    Stem Cells Dev; 2006 Feb; 15(1):70-8. PubMed ID: 16522164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of umbilical cord blood CD34+ hematopoietic stem cells expansion with inhibition of TGF-β receptorII in co-culture with bone marrow mesenchymal stromal cells.
    Sohrabi Akhkand S; Amirizadeh N; Nikougoftar M; Alizadeh J; Zaker F; Sarveazad A; Joghataei MT; Faramarzi M
    Tissue Cell; 2016 Aug; 48(4):305-11. PubMed ID: 27344285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coinhibition of activated p38 MAPKα and mTORC1 potentiates stemness maintenance of HSCs from SR1-expanded human cord blood CD34
    Li X; Ma X; Chen Y; Peng D; Wang H; Chen S; Xiao Y; Li L; Zhou H; Cheng F; Gao Y; Chang J; Cheng T; Liu L
    Stem Cells Transl Med; 2020 Dec; 9(12):1604-1616. PubMed ID: 32602209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial progenitor cells promote efficient ex vivo expansion of cord blood-derived hematopoietic stem/progenitor cells.
    Qu Q; Liu L; Chen G; Xu Y; Wu X; Wu D
    Cytotherapy; 2016 Mar; 18(3):452-64. PubMed ID: 26857234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of low O(2) concentration and mesenchymal stromal cells during culture of cord blood CD34(+) cells improves the maintenance and proliferative capacity of hematopoietic stem cells.
    Hammoud M; Vlaski M; Duchez P; Chevaleyre J; Lafarge X; Boiron JM; Praloran V; Brunet De La Grange P; Ivanovic Z
    J Cell Physiol; 2012 Jun; 227(6):2750-8. PubMed ID: 21913190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells.
    Jang YK; Jung DH; Jung MH; Kim DH; Yoo KH; Sung KW; Koo HH; Oh W; Yang YS; Yang SE
    Ann Hematol; 2006 Apr; 85(4):212-25. PubMed ID: 16391912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.